A batch of drugs for the treatment of patients with viral hepatitis С will arrive in the regions of Ukraine. Thanks to the supply of drugs, treatment will be possible for more than 18,000 patients with viral hepatitis C, according to information of the Center for Public Health of the Ministry of Health of Ukraine.
Purchased drugs are the latest direct-acting drugs that meet the recommendations of the WHO and the European Association for the Study of Liver Diseases for the treatment of hepatitis C. In particular, sofosbuvir / daclatasvir and sofosbuvir / velpatasvir are universal because they are effective against all C. The innovativeness of the course allows you to take the tablets for 3 or 6 months and does not require additional procedures, including the injection of drugs. Treatment is carried out by a single daily dose of drugs. Thanks to the combined approach, new drugs are much more effective, safer, the body responds more quickly to therapy, so treatment is much faster and more effective. For the treatment of viral hepatitis C, highly effective drugs are used, which have a low probability of side effects, in contrast to the drugs of the previous generation.
The effectiveness of the treatment is proven and reaches more than 90%.
Note that patients with viral hepatitis C, regardless of the stage of liver damage, can be completely cured. The earlier treatment is started, the higher the chances of recovery.